Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Therapeutic Potential of Butyrate for Treatment of Type 2 Diabetes

19 Oct 2021

Abstract excerpt

Metagenomics studies have shown that type 2 diabetes (T2D) is associated with an altered gut microbiota. Whereas different microbiota patterns have been observed in independent human cohorts, reduction of butyrate-producing bacteria has consistently been found in individuals with T2D, as well as in those with prediabetes. Butyrate is produced in the large intestine by microbial fermentations, particularly of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Diet and metabolism studies
Share to Gut microbiota and health
Share to Probiotics and Fermented Foods

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34737725
DOI: 10.3389/fendo.2021.761834

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Therapeutic Potential of Butyrate for Treatment of Type 2 DiabetesPMID 34737725Read ↗

Effect of Sodium Butyrate Supplementation on Type 2 Diabetes—Literature ReviewSemantic proximity Read ↗

Butyrate-producing human gut symbiont, Clostridium butyricum , and its role in health and diseaseSemantic proximity Read ↗

Butyrate as a promising therapeutic target in cancer: From pathogenesis to clinic (Review)Semantic proximity Read ↗

The epigenetic effects of butyrate: potential therapeutic implications for clinical practiceSemantic proximity Read ↗

Gut-Microbiota-Derived Metabolites and Probiotic Strategies in Colorectal Cancer: Implications for Disease Modulation and Precision TherapySemantic proximity Read ↗

The interplay between gut microbiota, short-chain fatty acids, and implications for host health and diseaseSemantic proximity Read ↗

Metabolic interplay of SCFA’s in the gut and oral microbiome: a link to health and diseaseSemantic proximity Read ↗

Probiotics for pancreatic β-cell function: from possible mechanism of action to assessment of effectivenessSemantic proximity Read ↗

Dietary butyrate ameliorates metabolic health associated with selective proliferation of gut Lachnospiraceae bacterium 28-4Semantic proximity Read ↗

The effect of butyrate-supplemented parenteral nutrition on intestinal defence mechanisms and the parenteral nutrition-induced shift in the gut microbiotaSemantic proximity Read ↗

Butyrate, a typical product of gut microbiome, affects function of the AhR gene, being a possible agent of crosstalk between gut microbiome, and hepatic drug metabolismSemantic proximity Read ↗

Metabolite mimicry identifies butyrate analogs with select protective functions in the intestinal mucosaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.